Governments and Ministries of Health around the world have requested that prior to the potential authorization of the Pfizer-BioNTech Covid-19 Vaccine, Pfizer send select training materials containing information for properly storing, preparing and administering the vaccine to anticipated vaccination sites. Although there is no guarantee that the vaccine will be authorized in every country, given the urgency of the pandemic, providing these materials in advance will enhance sites’ preparation. Materials, specifications and assumptions are subject to change. For the most up-to-date materials upon authorization, please visit www.cvdvaccine.com or www.comirnatyglobal.com. Pfizer will not begin shipment of the vaccine unless and until Emergency Use Authorization or Marketing Authorization has been granted in your country.